June 14, 2009

Fuad El-Hibri on Washington Post

Filed under: El-Hibri Fuad, Emergent BioSolutions, Emergent BioSolutions Inc, Fuad El-Hibri, Washington Post — Tags: Business, Chief executive officer, Compensation, Compensation and Benefits, Human Resources, Public company, SEC filing, Washington Post — fuadelhibri @ 6:29 pm

Fuad El-Hibri on Washington Post

Fuad El-Hibri / 2007 Executive Compensation Report

Title: Chairman and CEO
Company: Emergent BioSolutions
Industry: Biotechnology
Category: Public Companies

2007 Compensation Details

Total Compensation	$868,010
Salary	$509,100

Equity Gains & Retirement Plans

Company Performance

2007 Revenue	$152,732,000
Net income	$22,793,000

EBS

Recent Stock Price: 14.32

Company profile: EBS

• Stock Quote & News
• Earnings
• Press Releases
• SEC Filings

Sector Snapshot

Leave a Comment

• Pages:
  • About Fuad El-Hibri
  • Fuad El-Hibri Bio
• Blogroll
  • Blog at WordPress.com.
  • Blog at WordPress.com.
• Categories:
  • Abdul Aziz Said
  • Advisory Board
  • Allen Shofe
  • American Society of Hematology
  • American University
  • Anthrax Vaccine
  • AOL Money and Finance
  • Arab
  • Atlanta Business Chronicle
  • BacilleCalmette-Guerin
  • bio tech
  • BioDefense
  • BioPort
  • BioSpace
  • BioSpace.com
  • BioThrax
  • Brightkite
  • Business
  • Business Contracts
  • BusinessWeek
  • Chief executive officer
  • Chief financial officer
  • Chief Medical Officer
  • Clinical Research
  • Clinical Trial
  • colleagues
  • Congoo
  • Cornell University
  • CorridorInc
  • DailyPress
  • Digicel Holdings Ltd
  • Dr. Mary Elizabeth King
  • EdgarOnline
  • El-Hibri
  • El-Hibri Foundation
  • El-Hibri Fuad
  • El-Hibri Peace Education Prize
  • Emergent
  • Emergent BioDefense
  • Emergent BioSolutions
  • Emergent BioSolutions Inc
  • Entrepreneur
  • Ernst & Young
  • Ernst & Young Entrepreneur of the Year
  • EvaluatePharma
  • Federal Drug Administration
  • Financial Performance
  • Food and Drug Administration
  • Foundation
  • Fuad El-Hibri
  • Fuad Profiles
  • Fundrace
  • Fundrace 2008
  • Health Care Reform
  • Healthcare
  • Healthcare Conference
  • Highbeam
  • Hoovers
  • Huffington Post Fundrace
  • Ibrahim El-Hibri
  • ImpluCorporation
  • Infectious disease
  • Initial Public Offering
  • Investors
  • Lead411
  • Life Science Alliances World
  • Muckety
  • Music
  • National Health Museum
  • Netlog
  • Non-Hodgkin lymphoma
  • North Atlantic Treaty Organization
  • NuThrax
  • Peace Education
  • Profits and Losses
  • Recombinant Anthrax Vaccine
  • Research and development
  • Resource Center
  • Reuters
  • Revenue
  • rPA vaccines
  • Sample Business Contracts
  • Scholars Program
  • Shareholders
  • Shares
  • South Africa
  • TB Vaccine
  • Tech Council of Maryland
  • Trubion Pharmaceuticals
  • Tuberculosis Vaccine
  • Typhoid Vaccine
  • Uncategorized
  • United States
  • United States Department of Defense
  • United States Department of Health and Human Services
  • US Food and Drug Administration
  • USA Taoday
  • Washington
  • Washington Post
  • WatchDog.net
  • Xing
  • Yale Health Care
  • Yale School of Management
  • Yale University
  • ZoomInfo
• Search:
  
  
• Archives:
  • April 2012
  • March 2012
  • February 2012
  • November 2011
  • October 2011
  • September 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • January 2010
  • December 2009
  • October 2009
  • August 2009
  • July 2009
  • June 2009
• Meta:
  • Register
  • Log in
  • RSS
  • Comments RSS
  • Valid XHTML
  • XFN
  • Blog at WordPress.com.